Lung Cancers Completed Phase 1 Trials for Cetuximab (DB00002)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsTreatment
NCT01184482Lapatinib and Cetuximab in Patients With Solid TumorsTreatment